Valuation (33%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.92 | N/A |
PEG Ratio (TTM) | 0.07 | N/A |
P/S Ratio (TTM) | 3.40 | N/A |
P/B Ratio (TTM) | 0.77 | N/A |
P/FCF Ratio (TTM) | -0.88 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -33.16% | N/A |
ROE (TTM) | -62.22% | N/A |
Net Profit Margin (TTM) | -376.35% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -333.10% | 17.62% | N/A |
Revenue | 586.69% | 101.74% | N/A |
Net Income | -332.61% | -68.56% | N/A |
Cash Flow | -148.77% | -24.19% | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 5.36 | N/A |
Quick Ratio (TTM) | 5.36 | N/A |
D/E Ratio (TTM) | 0.17 | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 2 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |